Trials / Completed
CompletedNCT04258761
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")
A Multi-Center, Open Label, Single Ascending Dose Safety and Tolerability Study of Subcutaneously Administered 10XB-101 in Adult Subjects With Excessive Submental Fat
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- 10xBio, LLC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to find out more about an investigational drug, 10XB-101, for people with fat under their chin which they would like to remove. The Sponsor of this study thinks there may be a chance this drug could be used to dissolve, or "melt" this fat away.
Detailed description
About 15 subjects with excessive submental fat (SMF) will be enrolled across 2 sites in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 10XB-101 Solution for Injection | Active test article |
Timeline
- Start date
- 2019-10-10
- Primary completion
- 2022-06-30
- Completion
- 2022-08-31
- First posted
- 2020-02-06
- Last updated
- 2024-04-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04258761. Inclusion in this directory is not an endorsement.